Furukawa F, Sato H, Imaida K, Toyoda K, Imazawa T, Takahashi M, Hayashi Y
Division of Pathology, National Institute of Hygienic Sciences, Tokyo, Japan.
Pancreas. 1992;7(2):153-8. doi: 10.1097/00006676-199203000-00004.
The carcinogenic effects of N-methyl-N-nitrosourea (MNU) in male Syrian golden hamsters were investigated. After single i.p. administration of MNU at doses of 50 mg/kg or 10 mg/kg, or after five fractionated i.p. injections to make a total dose of 50 mg/kg body weight (10 mg x 5), histopathological examinations were performed at the end of 40th week of the experiment. Neoplastic changes were observed in various organs, and lesions in the pancreas, forestomach, and adrenal gland were predominant. In the pancreas, three tumor types were observed: ductal adenocarcinomas, acinar cell carcinomas, and islet cell carcinomas. The incidences of pancreatic ductal carcinomas were 56, 27, and 0% in the single 50-mg, fractionated 50-mg, and single 10-mg groups, respectively. Two islet carcinomas were observed in the single 50-mg group, and an islet carcinoma and an acinar cell carcinoma were also observed in the fractionated 50-mg group. Several miscellaneous neoplastic lesions, including squamous cell papillomas/carcinomas in the forestomach, cortical adenomas in the adrenal glands, and a seminoma in the testis were also observed. These results indicate MNU to be a multipotent carcinogen with the pancreas as a target organ in the Syrian golden hamster under this experimental condition. The observed high induction rate for pancreatic ductal carcinoma suggests that this MNU protocol is a useful candidate model for experimental pancreatic ductal carcinogenesis.
研究了N-甲基-N-亚硝基脲(MNU)对雄性叙利亚金仓鼠的致癌作用。以50mg/kg或10mg/kg的剂量单次腹腔注射MNU后,或进行五次腹腔注射分剂量给药,使总剂量达到50mg/kg体重(10mg×5),在实验第40周结束时进行组织病理学检查。在各个器官中均观察到肿瘤性变化,其中胰腺、前胃和肾上腺的病变最为突出。在胰腺中,观察到三种肿瘤类型:导管腺癌、腺泡细胞癌和胰岛细胞癌。单次50mg组、分次50mg组和单次10mg组的胰腺导管癌发生率分别为56%、27%和0%。在单次50mg组中观察到两例胰岛癌,在分次50mg组中还观察到一例胰岛癌和一例腺泡细胞癌。还观察到一些其他肿瘤性病变,包括前胃的鳞状细胞乳头状瘤/癌、肾上腺的皮质腺瘤和睾丸的精原细胞瘤。这些结果表明,在该实验条件下,MNU是一种多能致癌物,以叙利亚金仓鼠的胰腺作为靶器官。观察到的胰腺导管癌的高诱导率表明,这种MNU方案是实验性胰腺导管癌发生的一种有用的候选模型。